TACE Combined With Bevacizumab in HCC (BCLC-B) Beyond Up-To-Seven Criteria
Condition(s):Hepatocellular Carcinoma by BCLC StageLast Updated:May 31, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Hepatocellular Carcinoma by BCLC StageLast Updated:May 31, 2023Not yet recruiting
Condition(s):Hepatocellular CarcinomaLast Updated:January 12, 2024Recruiting
Condition(s):Primary Hepatocellular Carcinoma; Portal Vein ThrombosisLast Updated:May 24, 2023Not yet recruiting
Condition(s):Hepatocellular CarcinomaLast Updated:October 27, 2023Recruiting
Condition(s):Hepatocellular CarcinomaLast Updated:July 16, 2020Recruiting
Condition(s):Hepatocellular CarcinomaLast Updated:February 15, 2024Completed
Condition(s):HCCLast Updated:March 29, 2023Recruiting
Condition(s):Liver TumorLast Updated:September 26, 2022Recruiting
Condition(s):Hepatocellular CarcinomaLast Updated:September 24, 2021Unknown status
Condition(s):Advanced Hepatocellular CarcinomaLast Updated:August 20, 2019Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.